title: [Use of interferon inducers and reaferon in the combined therapy of acute viral hepatitis B].
abstract: The therapeutic effectiveness of interferon inducers (prodigiozan and ibuprofen), the Soviet drug reaferon and their combined use in acute viral hepatitis type B was studied. Indications for their use resulted from lowered capacity of the body for interferonogenesis at the height of the disease. The above drugs stimulated cellular immunity, promoted more rapid disappearance of clinical symptoms of disease, and reduced the period of hospital treatment. A more marked therapeutic effect was noted in combined administration of reaferon and ibuprofen.
authors.forename: M A
authors.initials: MA
authors.lastname: Andreĭchin
authors.forename: A S
authors.initials: AS
authors.lastname: Rudchik
authors.forename: V F
authors.initials: VF
authors.lastname: Borak
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000917:Antibody Formation / Q000187:drug effects; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007052:Ibuprofen / Q000009:adverse effects / Q000627:therapeutic use; D007111:Immunity, Cellular / Q000187:drug effects; D007369:Interferon Inducers / Q000009:adverse effects / Q000627:therapeutic use*; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D008875:Middle Aged; D011354:Prodigiozan / Q000009:adverse effects / Q000627:therapeutic use; D011994:Recombinant Proteins
chemical_list: D007369:Interferon Inducers; D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011354:Prodigiozan; D007052:Ibuprofen
vernacular_title: Primenenie interferonogenov i reaferona v kompleksnoĭ terapii ostrogo virusnogo gepatita B.